Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0JTQDR
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
FS-1502
|
|||||
| Synonyms |
FS-1502; IKS 014; IKS-014; IKS014; LCB14; Trastuzumab-LC-LBG-MMAF; Herceptin-LC-LBG-MMAF
Click to Show/Hide
|
|||||
| Organization |
Qilu Pharmaceutical Co., Ltd.
|
|||||
| Drug Status |
Phase 1
|
|||||
| Antibody Name |
Undisclosed
|
|||||
| Antigen Name |
Receptor tyrosine-protein kinase erbB-2 (ERBB2)
|
Antigen Info | ||||
| Payload Name |
Monomethyl auristatin F
|
Payload Info | ||||
| Therapeutic Target |
Microtubule (MT)
|
Target Info | ||||
| Linker Name |
Undisclosed
|
|||||
| Conjugate Type |
Random conjugation through reduced inter-chain cysteines.
|
|||||